About Cellero
Cellero is a Healthcare company based in Lowell (United States) founded in 2004, and was acquired by Charles River Laboratories in August 2020. Biomaterials and immune cell products are developed for health applications. Its chief executive, as recorded, is Jeffrey D Allen. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Developer of biomaterials, immune cell products for multiple health purposes. The companys proprietary platform involves research services and offers cryopreserved human immune cells, leukoplakia, and other blood products. It provides multiple services like assay development, product development, contract research, collection services, and others. Products include apheresis-derived platelets, whole blood, packed red blood cells, small volume whole blood samples, frozen leukoplakias, and many more.
- Headquarters Lowell, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellero.com
- Social LinkedIn X Facebook
- Acquired by Charles River Laboratories (Aug 2020)
- Investors
- Acquired byCharles River Laboratories
(Aug 2020)
Investors in Cellero
Cellero has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of drug discovery and preclinical development services | 1947 | criver.com | Wilmington, United States |
Investor details for Cellero
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cellero
1 people are tracked at Cellero (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeffrey D Allen | CEO & President | Leadership |
Complete people profiles for Cellero
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cellero
2 dated milestones of Cellero across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Cellero is founded.
- Exit Acquired by Charles River Laboratories.
Competitors of Cellero
Cellero has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Cellero
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cellero (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellero
Cellero was founded in 2004.
Cellero is headquartered in Lowell, United States. It is registered at Lowell, Massachusetts, United States.
Jeffrey D Allen is the CEO of Cellero, as recorded in our data.
Developer of biomaterials, immune cell products for multiple health purposes. The companys proprietary platform involves research services and offers cryopreserved human immune cells, leukoplakia, and other blood products. It provides multiple services like assay development, product development, contract research, collection services, and others. Products include apheresis-derived platelets, whole blood, packed red blood cells, small volume whole blood samples, frozen leukoplakias, and many more.
Cellero's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Cellero has 1 investor. Key investors include Charles River Laboratories.
Yes. Cellero was acquired by Charles River Laboratories in August 2020.